Evidence map›Paper›PMID 26474471›Full record

ArticlePLoS pathogens2015

Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus.

John You, Samantha D O'Hara, Palanivel Velupillai, Sherry Castle, Steven Levery, Robert L Garcea, Thomas Benjamin

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  3. Article
  4. Article
  5. Glycosphingolipid-Protein Interaction in Signal Transduction.International journal of molecular sciences · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

John YouDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Samantha D O'HaraBioFrontiers Institute and the Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado, United States of America.
Palanivel VelupillaiDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Sherry CastleDepartment of Chemistry, University of New Hampshire, Durham, New Hampshire, United States of America.
Steven LeveryDepartment of Chemistry, University of New Hampshire, Durham, New Hampshire, United States of America.
Robert L GarceaBioFrontiers Institute and the Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado, United States of America.
Thomas BenjaminDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Harvard University · USUniversity of Colorado Boulder · USUniversity of New Hampshire · US

Funding

MECHANISMS IN POLYOMA VIRUS ASSEMBLYR01CA037667 · NCI · UNIVERSITY OF COLORADO DENVER · PI GARCEA, ROBERT L · 1985 to 2018
$6.3M
TRAINING IN SIGNAL TRANSDUCTION &CELL CYCLE REGULATIONT32GM008759 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI AHN, NATALIE G. · 2000 to 2020
$5.9M
CELL ENTRY AND SPREAD BY POLYOMA VIRUSR01CA082395 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BENJAMIN, THOMAS LIVINGSTON · 2001 to 2010
$4.4M
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENTR01CA090992 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BENJAMIN, THOMAS LIVINGSTON · 2001 to 2005
$3.7M
Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
NCI NIH HHS R01 CA 037667NCI NIH HHS R01 CA037667NCI NIH HHS R01 CA 082395NCI NIH HHS R01 CA082395NCI NIH HHS R01 CA090992NCI NIH HHS R01 CA 90992NIGMS NIH HHS T32 GM008759NIGMS NIH HHS T32 GM142607
6 · The paper itself

Abstract

Gangliosides serve as receptors for internalization and infection by members of the polyomavirus family. Specificity is determined by recognition of carbohydrate moieties on the ganglioside by the major viral capsid protein VP1. For the mouse polyomavirus (MuPyV), gangliosides with terminal sialic acids in specific linkages are essential. Although many biochemical and cell culture experiments have implicated gangliosides as MuPyV receptions, the role of gangliosides in the MuPyV-infected mouse has not been investigated. Here we report results of studies using ganglioside-deficient mice and derived cell lines. Knockout mice lacking complex gangliosides were completely resistant to the cytolytic and pathogenic effects of the virus. Embryo fibroblasts from these mice were likewise resistant to infection, and supplementation with specific gangliosides restored infectibility. Although lacking receptors for viral infection, cells from ganglioside-deficient mice retained the ability to respond to the virus. Ganglioside-deficient fibroblasts responded rapidly to virus exposure with a transient induction of c-fos as an early manifestation of a mitogenic response. Additionally, splenocytes from ganglioside-deficient mice responded to MuPyV by secretion of IL-12, previously recognized as a key mediator of the innate immune response. Thus, while gangliosides are essential for infection in the animal, gangliosides are not required for mitogenic responses and innate immune responses to the virus.

Indexed as

Virus InternalizationAnimalsFlow CytometryFluorescent Antibody TechniqueGangliosidesHost-Pathogen InteractionsMiceMice, KnockoutMicroscopy, ConfocalPolyomavirusPolyomavirus InfectionsProto-Oncogene Proteins c-fosGangliosidesProto-Oncogene Proteins c-fos

Identifiers

PMID26474471
PMCPMC4608836
OpenAlexW2124859578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.